You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

Details for Patent: 4,861,760


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,861,760
Title: Ophthalmological composition of the type which undergoes liquid-gel phase transition
Abstract:The present invention relates to a pharmaceutical composition intended for contacting with a physiological liquid characterized in that said composition is intended to be administered as a non-gelled liquid form and is intended to gel in situ, this composition containing at least one polysaccharide in aqueous solution, of the type which undergoes liquid-gel phase transition gelling in situ under the effect of an increase in the ionic strength of said physiological liquid.
Inventor(s): Mazuel; Claude (Riom, FR), Friteyre; Marie-Claire (Riom, FR)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:06/911,606
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 4,861,760

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,861,760

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France85 14689Oct 03, 1985

International Family Members for US Patent 4,861,760

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0227494 ⤷  Sign Up 95C0013 Belgium ⤷  Sign Up
Austria 72990 ⤷  Sign Up
Australia 595240 ⤷  Sign Up
Australia 6318986 ⤷  Sign Up
Canada 1280367 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.